These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30455245)

  • 1. Preexposure to Isavuconazole Increases the Virulence of
    Wurster S; Lewis RE; Albert ND; Kontoyiannis DP
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455245
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Pfaller MA; Rhomberg PR; Wiederhold NP; Gibas C; Sanders C; Fan H; Mele J; Kovanda LL; Castanheira M
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
    Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
    Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
    Schwarz P; Schwarz PV; Felske-Zech H; Dannaoui E
    J Antimicrob Chemother; 2019 Jul; 74(7):1921-1927. PubMed ID: 30934052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
    Bellanger AP; Albert ND; Lewis RE; Walsh TJ; Kontoyiannis DP
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7830-2. PubMed ID: 26392499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens.
    Warrilow AGS; Parker JE; Price CL; Rolley NJ; Nes WD; Kelly DE; Kelly SL
    Int J Antimicrob Agents; 2019 Oct; 54(4):449-455. PubMed ID: 31310805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
    Denis J; Ledoux MP; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):8-14. PubMed ID: 29534853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Perkhofer S; Lechner V; Lass-Flörl C;
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1645-7. PubMed ID: 19164153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibility of cryptic species of Aspergillus fumigatus to isavuconazole, itraconazole and voriconazole by means of E-test].
    Falces-Romero I; Quiles-Melero I; García-Rodríguez J
    Rev Iberoam Micol; 2018; 35(2):113-114. PubMed ID: 29622510
    [No Abstract]   [Full Text] [Related]  

  • 10. In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.
    Arendrup MC; Jensen RH; Meletiadis J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7735-42. PubMed ID: 26438494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
    Messer SA; Carvalhaes CG; Castanheira M; Pfaller MA
    Diagn Microbiol Infect Dis; 2020 May; 97(1):115007. PubMed ID: 32081523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Wu X; Clancy CJ; Rivosecchi RM; Zhao W; Shields RK; Marini RV; Venkataramanan R; Nguyen MH
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.
    Jørgensen KM; Guinea J; Meletiadis J; Hare RK; Arendrup MC
    J Antimicrob Chemother; 2020 Sep; 75(9):2573-2581. PubMed ID: 32556315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Chowdhary A; Singh PK; Kathuria S; Hagen F; Meis JF
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7882-7. PubMed ID: 26438489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
    Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.
    Arendrup MC; Verweij P; Nielsen HV
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries.
    Verweij PE; González GM; Wiedrhold NP; Lass-Flörl C; Warn P; Heep M; Ghannoum MA; Guinea J
    J Chemother; 2009 Jun; 21(3):272-81. PubMed ID: 19567347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole for Treatment of Experimental Fungal Endophthalmitis Caused by Aspergillus fumigatus.
    Guest JM; Singh PK; Revankar SG; Chandrasekar PH; Kumar A
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201814
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Raffetin A; Courbin V; Jullien V; Dannaoui E
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.